论文部分内容阅读
目的:探析硫酸镁联合低分子肝素治疗子痫前期的临床效果。方法:选择2013年10月-2014年10月期间我院收治的子痫前期患者94例为研究对象,随机分为两组,其中给予对照组常规治疗,而观察组则运用硫酸镁和低分子肝素联合治疗,对比分析两组的治疗效果。结果:治疗后,观察组的凝血酶和凝血酶原时间延长明显优于对照组,并且相比较对照组而言,观察组的并发症发生率较低,组间比较有统计学意义(P<0.05)。结论:临床上运用硫酸镁和低分子肝素对子痫前期进行联合治疗,不仅可以延长孕周,在一定程度上还能降低并发症发生率,改善母婴结局。
Objective: To investigate the clinical effect of magnesium sulfate combined with low molecular weight heparin in the treatment of preeclampsia. Methods: Ninety-four patients with preeclampsia who were treated in our hospital from October 2013 to October 2014 were selected and divided into two groups at random. The patients in the observation group were treated with magnesium sulfate and low molecular weight Heparin combined treatment, comparative analysis of the two groups of treatment. Results: After treatment, the prolongation of thrombin and prothrombin time in the observation group was significantly better than that in the control group, and the complication rate was lower in the observation group compared with the control group, with statistical significance (P < 0.05). Conclusion: The combination therapy of magnesium sulfate and LMWH on preeclampsia can not only prolong the gestational age, but also reduce the complication rate and improve the maternal and infant outcome to a certain extent.